ACTN2 | Actinin, alpha 2 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
ACTN4 | Actinin, alpha 4 | Disease related genes Plasma proteins
| | | | | Expressed in all |
ACVR1 | Activin A receptor, type I | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACVR1B | Activin A receptor, type IB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ACVR2B | Activin A receptor, type IIB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ACVRL1 | Activin A receptor type II-like 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM29 | ADAM metallopeptidase domain 29 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAM9 | ADAM metallopeptidase domain 9 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMTS10 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAR | Adenosine deaminase, RNA-specific | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ADAT3 | Adenosine deaminase, tRNA-specific 3 | Disease related genes
| | | | | Mixed |
ADCK3 | AarF domain containing kinase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
ADCK4 | AarF domain containing kinase 4 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ADCY10 | Adenylate cyclase 10 (soluble) | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ADCY5 | Adenylate cyclase 5 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADK | Adenosine kinase | Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
ADSL | Adenylosuccinate lyase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
AFF2 | AF4/FMR2 family, member 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
AFF4 | AF4/FMR2 family, member 4 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGA | Aspartylglucosaminidase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
AGGF1 | Angiogenic factor with G patch and FHA domains 1 | Disease related genes
| | | | | Expressed in all |
AGK | Acylglycerol kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGPS | Alkylglycerone phosphate synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AGRN | Agrin | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
AGRP | Agouti related protein homolog (mouse) | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGT | Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AGXT | Alanine-glyoxylate aminotransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Tissue enriched |
AHCY | Adenosylhomocysteinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
AHI1 | Abelson helper integration site 1 | Disease related genes
| | | | | Expressed in all |
AIFM1 | Apoptosis-inducing factor, mitochondrion-associated, 1 | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AIMP1 | Aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 | Disease related genes
| | | | | Expressed in all |
AIP | Aryl hydrocarbon receptor interacting protein | Disease related genes Plasma proteins
| | | | | Expressed in all |
AIRE | Autoimmune regulator | Disease related genes Transcription factors
| | | | | Tissue enhanced |
AK1 | Adenylate kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |